Douglas Swirsky
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
MetaVia Inc. (MTVA)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
MetaVia Inc.
Current role
MTVA
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Maxcyte, Inc. (MXCT) | Former Chief Financial Officer | $491,000 | $1,225,057 |
| 2024 | Maxcyte, Inc. (MXCT) | Chief Financial Officer Ali Soleymannezhad Chief Commercial Officer | $460,000 | $1,686,574 |
| 2023 | Maxcyte, Inc. (MXCT) | Chief Financial Officer Ali Soleymannezhad Chief Commercial Officer | $326,129 | $1,189,934 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.